Leonie Konczalla
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
PD-L1-positive circulating tumor cells associate with tumor malignancy and impaired circulating immunity in patients with gastrointestinal tumors.
Journal: Scientific reports
Published: December 30, 2025
Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.
Journal: Nature
Published: May 13, 2025
IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction.
Journal: Journal of hepatology
Published: June 15, 2023
Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma.
Journal: Biomedicines
Published: September 01, 2022
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.
Journal: Nature
Published: February 15, 2022
Publisher Correction: TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer.
Journal: Nature communications
Published: November 07, 2020
Clinical Significance of Circulating Tumor Cells in Gastrointestinal Carcinomas.
Journal: Diagnostics (Basel, Switzerland)
Published: March 02, 2020
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans.
Journal: Gastroenterology
Published: September 20, 2019
Last Updated: 09/26/2026